Human Enhancement Freaks People Out, Study Finds; Designer Babies Might 'Meddle With Nature'
By Ed Cara,
Medical Daily
| 07. 26. 2016
Fond as we are of superheroes on the big screen, most of us would stop short of actually becoming one via technology.
That’s the verdict issued by an extensive survey conducted by the Pew Research Center and released Tuesday. The Center polled over 4,000 Americans on a variety of issues related to advances in biomedical technology that may arrive in the near future — from using implanted brain chips to boost our thinking power to editing the genes of babies to eliminate hereditary flaws and diseases. The representative sample of Americans proved to be more careful than celebratory about these technological leaps.
Sixty-eight percent were somewhat or very worried about gene-editing, as opposed to 49 percent who saw themselves as at least somewhat enthusiastic about the prospect. Sixty-nine percent were also wary of brain implants and 63 percent felt the same about using synthetic blood transfusions to improve our strength, speed, and stamina. A similar percentage were taken aback at the thought of trying these technologies out on themselves or their future children.
"Developments in biomedical technologies are accelerating rapidly, raising...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...